PubRank

Laurent Zini

Author PubWeight™ 26.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 2009 2.41
2 Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol 2011 1.87
3 Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist. Urology 2009 1.58
4 External validation of the updated partin tables in a cohort of French and Italian men. Int J Radiat Oncol Biol Phys 2008 1.58
5 Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. Urology 2008 1.55
6 Thirty-day mortality after nephrectomy: clinical implications for informed consent. Eur Urol 2008 1.53
7 A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol 2009 1.35
8 A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int 2008 1.20
9 Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53. Arch Pathol Lab Med 2007 1.06
10 Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 2010 1.05
11 Conditional survival predictions after nephrectomy for renal cell carcinoma. J Urol 2009 1.02
12 Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases. Am J Surg Pathol 2007 1.01
13 MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma. Am J Clin Pathol 2002 0.93
14 Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod Pathol 2002 0.92
15 Isolation and characterization of a primary proximal tubular epithelial cell model from human kidney by CD10/CD13 double labeling. PLoS One 2013 0.89
16 Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy. BJU Int 2009 0.87
17 Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia. J Urol 2009 0.84
18 Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int 2008 0.83
19 Survival of patients with nonmetastatic pT3 renal tumours: a matched comparison of laparoscopic vs open radical nephrectomy. BJU Int 2009 0.82
20 Intraurethral transfer of satellite cells by myofiber implants results in the formation of innervated myotubes exerting tonic contractions. J Urol 2007 0.82
21 National prospective study on the use of local haemostatic agents during partial nephrectomy. BJU Int 2013 0.80
22 Cystic renal cell carcinomas in adults. Is preoperative recognition of multilocular cystic renal cell carcinoma possible? J Urol 2005 0.80
23 Polytetrafluoroethylene expanded prosthesis as replacement of the inferior vena cava in renal cell carcinoma with caval thrombus. Int J Urol 2014 0.80
24 Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma? Bull Cancer 2012 0.79
25 Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort. Urology 2009 0.78
26 Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma). BJU Int 2009 0.75
27 Celiac axis and superior mesenteric artery: danger zone for left nephrectomy. J Endourol 2008 0.75
28 [Cell therapy and tissue engineering in urology]. Prog Urol 2005 0.75
29 [Cell therapy for urethral sphincter incompetence by muscle precursor cell autograft]. Prog Urol 2004 0.75
30 Limited prognostic value of tumor necrosis in patients with renal cell carcinoma. Urology 2009 0.75
31 Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy. J Endourol 2009 0.75